The comorbid association of migraine with osteoarthritis and hypertension: Complement C3F and Berkson's bias

Cephalalgia

Volumn 17, Issue 1, 1997, Pages 23-26

  Peroutka, S J ^a   Price, S C ^a   Jones, K W ^a  

^a Spectra Biomedical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3;

ADULT; ARTHRITIS; ARTICLE; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HEALTH CARE UTILIZATION; HEART DISEASE; HUMAN; HUMAN TISSUE; HYPERTENSION; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MIGRAINE; MORBIDITY; OSTEOARTHRITIS; STATISTICAL ANALYSIS;

COMORBIDITY; COMPLEMENT C3C; CORONARY DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MIGRAINE DISORDERS; OSTEOARTHRITIS; POLYMORPHISM, GENETIC;

EID: 0031040643     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1701023.x     Document Type: Article

References (28)

1. Kurtzke JF. The current neurologic burden of illness and injury in the United States. Neurology 1982;32:1207-14
2. Stewart WF, Lipton RB. Migraine headache: epidemiology and health care utilization. Cephalalgia 1993;13 Suppl 12:41-6
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:1-90
4. Peatfield RC, Fozard JR, Rose FC. Drug treatment of migraine. Handbook of clinical neurology 1986;4:173-216
5. Welch KMA. Drug therapy of migraine. New Engl J Med 1993;329:1476-83
6. Peroutka SJ. Drugs effective in the therapy of migraine. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. The pharmacological basis of therapeutics 1996:487-502
7. Stang PE, Osterhaus JT, Celentano DD. Migraine patterns of healthcare use. Neurology 1994;44:S47-55
8. Sternfeld B, Stang P, Sidney S. Relationship of migraine headaches to experience of chest pain and subsequent risk for myocardial infarction. Neurology 1995;45:2135-42
9. Leviton A, Malvea B, Graham JR. Vascular diseases, mortality, and migraine in the parents of migraine patients. Neurology 1974;24:669-72
10. Couch JR, Hassanein RS. Headache as a risk factor in atherosclerosis-related diseases. Headache 1989;29:49-54
11. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Arch Gen Psychiatry 1990;47:849-53
12. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991;37:11-23
13. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology 1994;44:S17-22
14. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the U.S. Pharmaco Economics 1992;2:67-76
15. Russell MB, Diesen J. The genetics of migraine without aura and migraine with aura. Cephalalgia 1993;13:245-8
16. Peroutka SJ, Howell TA. The genetic evaluation of migraine: clinical database requirements. In: Rose FC, editor. Leeds Castle Migraine Workshop, 1996 (in press)
17. Botto M, Fong KY, So AK, et al.. Molecular basis of polymorphisms of human complement component C3. J Exp Med 1990;172:1011-7
18. Wieme RJ, Demeulenaere L. Genetically determined electrophoretic variant of the human complement component C′3. Nature 1967;214:1042-3
19. Alper CA, Propp RP. Genetic polymorphism of the third component of human complement (C′3). J Clin Invest 1968;47:2181-91
20. Farhud DD, Ananthakrishnan R, Walter H. Association between C′3 phenotypes and various diseases. Humangenetik 1972;17:57-60
21. Puttick AH, Briggs DC, Welsh KI, et al. Genes associated with rheumatoid arthritis and mild inflammatory arthritis. II. Association of HLA with complement c3 and immunoglobulin Gm allotypes. Ann Rheum Dis 1990;49:225-8
22. F-Gene in essential hypertension. Circulation 1978;58:622-5
23. F-gene and essential hypertension. Clin Sci 1981;61 Suppl 7:363-5
24. Dissing J, Lund J, Sørensen H. C3 polymorphism in a group of old arteriosclerotic patients. Hum Hered 1972;22:466-72
25. Sørensen H, Dissing J. Association between the C3F gene and atherosclerotic vascular diseases. Hum Hered 1975;25:279-83
26. De Bruijn MHL, Fey GH. Human complement component C3: DNA coding sequence and derived primary structure. Proc Natl Acad Sci USA 1985;82:708-12
27. Cavalli-Sforza LL, Menozzi P, Piazza A. The history and geography of human genes. Princeton: Princeton University Press, 1994
28. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics 1946;2:47-53